Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count

Stefano Lancellotti, A Dragani, P Ranalli, Giovanna Petrucci, Maria Basso, Raffaele Tartaglione, Bianca Rocca*, Raimondo De Cristofaro

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolopeer review

25 Citazioni (Scopus)

Abstract

Essential thrombocythemia (ET) is characterized by increased platelets and prevalent thrombosis. An acquired Von Willebrand factor (VWF) disease has been hypothesized and inconsistently associated with extreme thrombocytosis or rare bleedings in ET. Whether VWF is modified in ET patients with controlled platelet count remains unclear.
Lingua originaleInglese
pagine (da-a)1226-1237
Numero di pagine12
RivistaJournal of Thrombosis and Haemostasis
Volume13
Numero di pubblicazione7
DOI
Stato di pubblicazionePubblicato - 2015

All Science Journal Classification (ASJC) codes

  • Ematologia

Keywords

  • ADAMTS13 protein
  • Essential Thrombocythemia
  • Glycocalicin
  • Platelet Membrane Glycoprotein V
  • Von Willebrand Factor
  • human

Fingerprint

Entra nei temi di ricerca di 'Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count'. Insieme formano una fingerprint unica.

Cita questo